Filing Details

  

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

 

(Amendment No. 1)*

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

Oncobiologics, Inc.

(Name of Issuer)

 

Common Stock, par value $0.01

(Title of Class of Securities)

68235M105

(CUSIP Number)

 

December 31, 2017

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

o

Rule 13d-1(b)

 

þ

Rule 13d-1(c)

 

o

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosure provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of the section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP No.

68235M105

 

1	NAME OF REPORTING PERSON   PointState Fund LP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)       o (b)       o
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER 0
		6	SHARED VOTING POWER 1,313,252
		7	SOLE DISPOSITIVE POWER 0
		8	SHARED DISPOSITIVE POWER 1,313,252
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,313,252
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 4.9%
12	TYPE OF REPORTING PERSON PN

 

 

CUSIP No.

68235M105

 

1	NAME OF REPORTING PERSON   PointState Holdings LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)       o (b)       o
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER 0
		6	SHARED VOTING POWER 1,452,934
		7	SOLE DISPOSITIVE POWER 0
		8	SHARED DISPOSITIVE POWER 1,452,934
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,452,934
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.4%
12	TYPE OF REPORTING PERSON OO

 

 

CUSIP No.

68235M105

 

1	NAME OF REPORTING PERSON   PointState Capital LP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)       o (b)       o
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER 0
		6	SHARED VOTING POWER 1,453,000
		7	SOLE DISPOSITIVE POWER 0
		8	SHARED DISPOSITIVE POWER 1,453,000
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,453,000
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.4%
12	TYPE OF REPORTING PERSON IA, PN

  

 

CUSIP No.

68235M105

 

1	NAME OF REPORTING PERSON   PointState Capital GP LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)       o (b)       o
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER 0
		6	SHARED VOTING POWER 1,453,000
		7	SOLE DISPOSITIVE POWER 0
		8	SHARED DISPOSITIVE POWER 1,453,000
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,453,000
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.4%
12	TYPE OF REPORTING PERSON OO

 

 

CUSIP No.

68235M105

 

1	NAME OF REPORTING PERSON   Zachary J. Schreiber
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)       o (b)       o
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER 0
		6	SHARED VOTING POWER 1,453,000
		7	SOLE DISPOSITIVE POWER 0
		8	SHARED DISPOSITIVE POWER 1,453,000
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,453,000
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.4%
12	TYPE OF REPORTING PERSON IN

 

 

Item 1(a)

Name of Issuer

 

The name of the issuer is Oncobiologics, Inc. (the “Company”).

 

Item 1(b)

Address of Issuer’s Principal Executive Offices

 

The Company’s principal executive offices are located at:
7 Clarke Drive, Cranbury, New Jersey 08512.

 

Item 2(a)

Name of Person Filing

 

This statement is filed by:

 

(i)

PointState Fund LP, a Delaware limited partnership (“PointState Fund”);

 

(ii)

PointState Holdings LLC, a Delaware limited liability company (“PointState Holdings”), which serves as the general partner of SteelMill Master Fund, LP, a Cayman Islands exempted limited partnership (“SteelMill”) and PointState Fund;

 

(iii)

PointState Capital LP, a Delaware limited partnership (“PointState”), which serves as the investment manager of (i) SteelMill, (ii) PointState Fund and (iii) Conflux Fund LP, a Delaware limited partnership (“Conflux”);

 

(iv)

PointState Capital GP LLC, a Delaware limited liability company (“PointState GP”), which serves as the general partner of PointState; and

 

(v)

Zachary J. Schreiber (“Mr. Schreiber”), who serves as managing member of (i) PointState Holdings, (ii) PointState GP and (iii) Conflux Holdings LLC, which serves as the general partner of Conflux.

 

PointState Fund, PointState Holdings, PointState, PointState GP and Mr. Schreiber are hereinafter sometimes collectively referred to as the “Reporting Persons.” SteelMill, PointState Fund and Conflux are hereinafter sometimes collectively referred to as the “Funds.” Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.

 

The Reporting Persons are filing this statement jointly with respect to the same securities as contemplated by Rule 13d-1(k)(1), not as members of a group.

 

Item 2(b)

Address of Principal Business Office or, if None, Residence

 

The address of the business office of each of the Reporting Persons is care of PointState Capital LP, 40 West 57^th Street, 25^th Floor, New York, NY 10019.

 

 

Item 2(c)

Citizenship

 

PointState Fund, PointState Holdings, PointState, and PointState GP are organized under the laws of Delaware. Mr. Schreiber is a citizen of the United States of America.

 

Item 2(d)

Title of Class of Securities

 

Common Stock, par value $0.01 per share (“Common Shares”).

 

Item 2(e)

CUSIP No.

 

68235M105

 

Item 3.

If This Statement Is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

 

N/A

 

Item 4.

Ownership

 

The Funds are the direct holders of warrants that may be exercised to purchase 1,453,000 Common Shares, including 1,313,252 warrants held by PointState Fund.

 

The information in Items 5 through 9 and Item 11 on the cover pages to this Schedule 13G is hereby incorporated by reference.

 

All percentages of Common Shares outstanding contained herein assume that 25,530,722 Common Shares are outstanding as of December 27, 2017, as disclosed on the Company’s Form 10-Q/A, filed with the Securities and Exchange Commission on January 29, 2018.

Item 5.

Ownership of Five Percent or Less of a Class

 

N/A

 

Item 6.

Ownership of More Than Five Percent on Behalf of Another Person

 

The Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the Company securities held by them; except as set forth herein, the interest of any one such Fund does not exceed 5% of the Common Shares.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company

 

The information in Items 2 and 4 is hereby incorporated by reference.

 

Item 8.

Identification and Classification of Members of the Group

 

N/A

 

 

Item 9.

Notice of Dissolution of Group

 

N/A

 

Item 10.

Certification

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 14, 2018

 

	POINTSTATE FUND LP
	By: PointState Capital LP, as its investment manager
	By: PointState Holdings LLC, as its general partner
	By:	/s/ Zachary J. Schreiber
		Name:  Zachary J. Schreiber
	POINTSTATE HOLDINGS LLC
	By:	/s/ Zachary J. Schreiber
		Name:  Zachary J. Schreiber
		Title:  Managing Member
	POINTSTATE CAPITAL LP
	By:	/s/ Zachary J. Schreiber
		Name:  Zachary J. Schreiber
		Title:  Managing Member
	POINTSTATE CAPITAL GP LLC
	By:	/s/ Zachary J. Schreiber
		Name:  Zachary J. Schreiber
		Title:  Managing Member
	By:	/s/ Zachary J. Schreiber
		Name:  Zachary J. Schreiber